Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• VillanuevaALlovetJMTargeted therapies for hepatocellular carcinomaGastroenterology201114051410142621406195
   PubMed Web of Science ®Google Scholar
• AsgharUMeyerTAre there opportunities for chemotherapy in the treatment of hepatocellular cancer?J Hepatol201256368669521971559
   PubMed Web of Science ®Google Scholar
• BroxtermanHJGeorgopapadakouNHAnticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinationsDrug Resist Updat20058418319716154800
   PubMed Web of Science ®Google Scholar
• GrecoFVicentMJCombination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicinesAdv Drug Deliv Rev200961131203121319699247
   PubMed Web of Science ®Google Scholar
• SaraswathyMGongSDifferent strategies to overcome multidrug resistance in cancerBiotechnol Adv20133181397140723800690
   PubMed Web of Science ®Google Scholar
• VinodBSMaliekalTTAntoRJPhytochemicals as chemosensitizers: from molecular mechanism to clinical significanceAntioxid Redox Signal201318111307134822871022
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• HuCMAryalSZhangLNanoparticle-assisted combination therapies for effective cancer treatmentTher Deliv20101232333422816135
   PubMedGoogle Scholar
• LivneyYDAssarafYGRationally designed nanovehicles to overcome cancer chemoresistanceAdv Drug Deliv Rev20136513–141716173023954781
   PubMed Web of Science ®Google Scholar
• DeepaKSinghaSPandaTDoxorubicin nanoconjugatesJ Nanosci Nanotechnol201414189290424730306
   PubMed Web of Science ®Google Scholar
• GuoLFanLRenJA novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomesNanotechnology2011222626510521586819
   PubMed Web of Science ®Google Scholar
• LiuYLiLLQiGBChenXGWangHDynamic disordering of liposomal cocktails and the spatio-temporal favorable release of cargoes to circumvent drug resistanceBiomaterials201435103406341524456605
   PubMedGoogle Scholar
• ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsSmall20095232673267719780069
   PubMed Web of Science ®Google Scholar
• MengHLiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• WilkenRVeenaMSWangMBSrivatsanESCurcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinomaMol Cancer2011101221299897
   PubMed Web of Science ®Google Scholar
• GantaSAmijiMCoadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cellsMol Pharm20096392893919278222
   PubMed Web of Science ®Google Scholar
• SharmaRAGescherAJStewardWPCurcumin: the story so farEur J Cancer200541131955196816081279
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKCoformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cellsMol Pharm20118385286621480667
   PubMed Web of Science ®Google Scholar
• WangBLShenYMZhangQWCodelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancerInt J Nanomedicine201383521353124101869
   PubMedGoogle Scholar
• DuanJMansourHMZhangYReversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticlesInt J Pharm20124261–219320122274587
   PubMed Web of Science ®Google Scholar
• BaruiSSahaSMondalGHaseenaSChaudhuriASimultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculatureBiomaterials20143551643165624239109
   PubMed Web of Science ®Google Scholar
• CalixtoGBernegossiJFonseca-SantosBChorilliMNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewInt J Nanomedicine201493719373525143724
   PubMed Web of Science ®Google Scholar
• KangKWChunMKKimODoxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapyNanomedicine20106221021320060074
   PubMed Web of Science ®Google Scholar
• WongHLRauthAMBendayanRA new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cellsPharm Res20062371574158516786442
   PubMed Web of Science ®Google Scholar
• VanditaKShashiBSantoshKGPalKIEnhanced apoptotic effect of curcumin loaded solid lipid nanoparticlesMol Pharm20129123411342123127155
   PubMedGoogle Scholar
• PugliaCFrascaGMusumeciTCurcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in miceEur J Pharm Biopharm201281228829322504443
   PubMedGoogle Scholar
• ZhangCPengFLiuWNanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male ratsInt J Nanomedicine201491049106324591827
   PubMed Web of Science ®Google Scholar
• ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release2006110229630616325954
   PubMed Web of Science ®Google Scholar
• LeeESNaKBaeYHDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJ Control Release2005103240541815763623
   PubMed Web of Science ®Google Scholar
• IwaiSMuraiTMakinoSHigh sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 miceCancer Lett20072461–211512116569478
   PubMedGoogle Scholar
• PardeikeJWeberSHaberTDevelopment of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary applicationInt J Pharm20114191–232933821839157
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254Suppl 1S131S15512460720
   PubMed Web of Science ®Google Scholar
• WohlfartSKhalanskyASGelperinaSEfficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizersPLoS One201165e1912121573151
   PubMed Web of Science ®Google Scholar
• HouDXieCHuangKZhuCThe production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials200324101781178512593960
   PubMed Web of Science ®Google Scholar
• ZhuRRQinLLWangMPreparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticlesNanotechnology200920505570219417361
   PubMed Web of Science ®Google Scholar
• ChenCCTsaiTHHuangZRFangJYEffects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokineticsEur J Pharm Biopharm201074347448220060469
   PubMed Web of Science ®Google Scholar
• YeJWangALiuCChenZZhangNAnionic solid lipid nanoparticles supported on protamine/DNA complexesNanotechnology2008192828570821828742
   PubMed Web of Science ®Google Scholar
• RitgerPLPeppasNAA simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJ Control Release1987513742
   Google Scholar
• BarraudLMerlePSomaEIncrease of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJ Hepatol200542573674315826724
   PubMed Web of Science ®Google Scholar
• ThambiTDeepaganVGYoonHYHypoxia-responsive polymeric nanoparticles for tumor-targeted drug deliveryBiomaterials20143551735174324290696
   PubMed Web of Science ®Google Scholar
• GuoYChuMTanSChitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistanceMol Pharm2014111597024229050
   PubMedGoogle Scholar
• ChiangWHHuangWCChangCWFunctionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imagingJ Control Release2013168328028823562635
   PubMedGoogle Scholar
• FanHTianWMaXCurcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthaseTarget Oncol20149327928623821378
   PubMed Web of Science ®Google Scholar
• QianHYangYWangXCurcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagyEur J Pharm Sci201143312513121514382
   PubMed Web of Science ®Google Scholar
• LiXLuXXuHPaclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy”Mol Pharm20129222222922171565
   PubMed Web of Science ®Google Scholar